Region: United States of America

Soaring US patent litigation funding triggers intense disclosure debate

Third-party backing is at an all-time high, but questions linger over how much should be public

07 October 2022

Five SCOTUS developments that life sciences IP professionals need to know about

The past two weeks have seen a flurry of patent-related activity at the US Supreme Court

07 October 2022

SCOTUS signals willingness to tackle skinny label questions worrying generic drug industry

The Supreme Court's request for Solicitor General input increases the chances of a hearing on skinny-label controversies

06 October 2022

Apple to pay $134M annually for renewed InterDigital patent licence

The seven-year agreement will yield nearly $940 million over its lifetime; now the licensing company must re-negotiate Samsung’s deal expiring at year end

05 October 2022

USPTO Director Kathi Vidal finds OpenSky Industries abused inter partes review process

A precedential director review ruling over attempt to extract payment from VLSI propels Intel Corp to lead petitioner in case

04 October 2022

A roadmap for monetising under-utilised patents

Extracting value from IP is increasingly relevant for companies of all sizes, and owners should look into their existing portfolios as a potential new source of revenue

04 October 2022

Waco jury awards $273 million damages in first battle of David-v-Goliaths licensing campaign

Ravgen is pursuing several large diagnostics companies in patent enforcement drive

04 October 2022

Top 10 busiest PTAB expert witnesses

Docket Navigator’s new tool shows the most in-demand specialist focuses on multiplex and VoIP technology

03 October 2022

Drug royalty sales supercharged by sinking biotech valuations, says leading dealmaker

Following the firm’s recent $115 million investment, Sagard Healthcare Royalty Partners’ Ali Alagheband says a flurry of activity is underway in the market

03 October 2022

Uniloc v Motorola Mobility appeal will not disrupt patent litigation finance industry

Saturday Opinion: While IP professionals may welcome opportunity for legal clarity on standing, warnings of harmful impacts on litigation financing are overblown

01 October 2022

Unlock unlimited access to all IAM content